DY determinants, possibly associated with novel class II molecules, stimulate autoreactive CD4+ T cells with suppressive activity by unknown
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The human MHC comprises loci encoding at least three main segregant series
of polymorphic HLA class II products, HLA-DR, -DQ, and -DP. These appear
tohave broadly similar functions, at least in vitro, sinceall can serveas restriction
elements for Tcell antigen recognition (1-3), as alloantigenic targets for T cell-
mediated cytolysis (4-6), and as stimulatory antigens for lymphoproliferative
responses (6). Quite probably, not all class II products have even now been
identified and characterized at the protein level (7). Further, the presence of
additional class 11 genes, DOf and DZa, hasalso been reported (8, 9). No surface
products ofthese genes have yet been identified, although they are expressed at
the mRNA level (8, 9). The existence of more class II molecules derived by
transcomplementation (10) or present as mixed isotypes (11, 12) is also to be
expected.
mAbs reacting specifically with DR, DQ, or DP molecules have proven critical
in investigating the structure and function ofclass II moieties. Moreover, mAbs
reacting with epitopes broadly distributed on products of more than one locus
may be informative in the definition of potential novel class II molecules (7).
Using mAb TU39, which appears to possess such a uniquely broad reactivity,
leukemias of different lineages were often shown to contain a much lower
percentage of DR', DP', and DQ+ cells than ofTU39+ cells (13, 14). This extra
reactivity could be interpreted as reflecting the reactivity of mAb TU39 with
class II molecules additional to the established DR, DQ, or DP series .
In a complementary approach, the identification ofnovel class II antigens may
be accomplished by using cloned lines from in vitro primings between allogeneic
donors thatched for established class II specificities, and by blocking their
stimulation with class II-specific mAbs. HLA-DP antigens were first demon-
strated with such a primed lymphocyte typing (PLT)' technique (15). Using a
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similar rationale we previously reported (16) apparently novel lymphocyte-
activating determinants (LADS) showing little polymorphism in the population,
whose stimulation could be blocked by mAb TU39, but not by a number of
other less broadly reactive class II-specific mAbs. These LADS have been
operationally designated DY (14). The CD4' cloned lines responding to DY
LADs exhibited weak and poorly biphasic proliferative responses not associated
with the presence of any identifiable HLA specificity on the stimulating cells
(16). Such DY-reactive T cell clones (TCC) were also unusual in their ability to
inhibit proliferative responses of other lymphocytes in an apparently HLA-
unrestricted fashion (16). In the present report it is shown that cells stimulated
by DY determinants display autoreactivity and could therefore constitute a self-
maintaining circuit with suppressive activity for lymphocyte proliferation (LP).
Stimulation of LP and induction of suppressive activity via DY is shown not to
be blocked by mAbs specific for DR, DP, or DQ, but is blocked by mAb SG520
and TU39. The latter mAb is shown to precipitate a putative novel class II-like
non-DR, -DQ, -DP molecule, which is therefore a good candidate for the
structure bearing DY determinants.
Materials and Methods
Lymphocyte Priming.
￿
Peripheral blood mononuclear cells (PBMC) from donors typed
for HLA-A, B, C, DR, Dw, DQw, and DPw antigens were isolated by density gradient
centrifugation. Stimulator cells were 7-irradiated at 20 Gy and mixed with unirradiated
responding cells in equal amounts at 10' cells/ml. Priming cultures were performed
between DR/Dw and DQ phenotypically matched donors in 16-mm-diameter cluster plate
wells (Costar, Cambridge, MA) or 25-cm2 tissue culture flasks (Falcon Labware, Oxnard,
CA) in medium consisting of RPMI 1640 + 25 mM Hepes supplemented with 10% heat-
inactivated pooled nontransfused male serum, with antibiotics. After 6 d, cultures were
supplemented with 20% vol/vol of conditioned medium (Lymphocult T; Biotest, Frank-
furt, Federal Republic ofGermany) to a final concentration equivalent to 20 U/ml of IL-
2. After 10 d, the cultures were harvested, washed, and restimulated with twice their
number of cells from the original stimulating cell donor, in fresh medium supplemented
with Lymphocult T. After a further 4 d, PLT reagents were harvested and cryopreserved
for use in PLT tests.
Cloning and Cell Line Propagation. PLT cells were restimulated with the original
priming cells in Costar wells in medium supplemented with 20% of Lymphocult T, using
2 x 10' primed cells plus 4 x 105 stimulators in 2 ml medium with IL-2 at 20 U/ml. After
4 d, cells were cloned at limiting dilution and cultured by intermittent feeding with fresh
medium (every 2-4 d) and periodic restimulation with specific stimulator PBMC (every 7
d) . Limiting dilution was performed in 1-mm diameter culture wells, seeding 0.3-0.45
cells/well with 104 30 Gy irradiated PBMC stimulator cells. Control plates containing 4.5
and 45 cells/well were set up to ensure single-hit characteristics of the limiting dilution
curves (r > 0.9). Contents of wells containinggrowing cells were transferred at 7-10 d to
7-mm diameter culture wells with 105 stimulator cellsand fresh medium . After a further
3-5 d, cells were transferred to Costar wells, where they were maintained as above, using
pooled lymphocytes from at least 20 donors as stimulators.
PLT Restimulation.
￿
Primed cells, cultured cells, and cloned cells were restimulated in
U-well microtiter plates, generally using 104 responders and 105 stimulators (PBMC) per
well . B-lymphoblastoid cell lines (B-LCL) and cloned TCC stimulators were used at lower
cell numbers. PBMC and TCC were irradiated at 20 Gy and B-LCL at 80 Gy. Culture
kinetic was varied. Medium was RPMI, 25 mM Hepes, 10% human serum, and antibiotics.
37 kBq/well ["H]TdR (sp act, 185 GBq/mmol; Amersham Corp., Arlington Heights, IL)
was added 18 h before termination of the cultures.PAWELEC ET AL.
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Quantification of IL-2 Secretion.
￿
Supernatants of specifically stimulated T cell clones
were prepared by incubating 4 x 106 cloned cells with 5 x 10 80 Gy-irradiated B-LCL
in 2 ml of medium containing 1% HS for 48 h. To quantitate IL-2 production, superna-
tants were titrated onto IL-2-dependent T cell lines and ['H]TdR incorporation was
measured after 24 h. Highly purified natural IL-2 (Lymphocult T-HP; Biotest) was used
as a positive control, and Probit analysis was applied on an IBM-PC (program by Blaurock,
M., G. Pawelec, and P. Wernet, submitted for publication) to calculate units of IL-2 with
reference to the International Union of Immunological Societies-Biological Response
Modifiers Program (IUIS-BRMP) standard.
mAbInhibition ofStimulation.
￿
mAbs were added to restimulationassays at the initiation
of culture and remained present for the duration of the assay. Stimulating cells were
plated first, followed by mAbs, and lastly, after a short pause, the responding cells were
plated. Previous experiments with the Tubingen series mAbs used here (TU22, anti-DQ;
TU34, TU37, anti-DR; and TU59, binding the products of at least DR and DP) had
provided no evidence of stimulation-inhibition mechanisms divorced from effects of the
mAbs binding to the stimulating cells (17, 18). Nonetheless, in certain experiments,
stimulating cells were pretreated with mAbs by incubating in undiluted hybridoma
supernatant at 4°C for 1 h, followed by washing three times in cold medium, and
immediate addition to culture wells already containing the responders. B-LCL used as
stimulators had been shown by FACS analysis to bind strongly the mAbs used in the
blocking experiments, although the level of expression of DQ and DP antigens was almost
always lower than that of DR antigens (data not shown). TO mAbs (13, 14, 17-20) were
used as tissue culture supernatants (25%, 1-3 ttg/ml), other mAbs as a 1:100 dilution of
ascites. Additional mAbs used were as follows: L243 (6), Q2/70 (18, 20), and SG157 (18)
specific for HLA-DR (although Q2/70 may also bind DQ, reference 20); SPV-L3 (4) and
Leu10 (18) specific for DQw and DQw1,3 molecules, respectively; B7/21, specific for
HLA-DP (5, 15); and PL5 (6), DA6.231 (6, 18), and SG520 (6, 18) "broadly" reactive
with multiple class II molecules. mAb B7/21 (anti-FA) ascites was a kind gift of F. Bach,
Immunobiology Research Center, Minneapolis, MN, and the B7/21 hybridoma was a
generous gift of I. Trowbridge, Salk Institute, San Diego, CA; SPV-L3 was from J. de
Vriesand H. Spits, UNICET, Dardilly, France; SG157 and SG520 came from S. Goyert,
Hospital forJoint Diseases, New York; DA6.231 was from K. Guy, MRC Clinical and
Population Cytogenetics Unit, Edinburgh, Scotland; Q2/70 was from S. Ferrone, New
York Medical College, New York; PL5 was from R. Knowles, Memorial Sloan-Kettering
Cancer Center, New York; and Leu10 and L243 were from Becton Dickinson & Co.,
Mountain View, CA.
Sequential Immunodepletion Procedures. For immunoprecipitation studies, mAbs
L243, TU22, B7/21, and TU39 were purified by protein A-Sepharose 4B affinity
chromatography according to Ey et al . (21).
TCC were biosynthetically labeled by resuspending 4 x 10' exponential growth phase
cells in 4 ml MEM without L-methionine. The medium was supplemented with 5%
methionine-free(dialyzed three times) human serum and 20 U/ml IL-2, and, after 1 h at
37°C, with 18,500 kBq of ['
nS]methionine (3.7 x 10'°Bq/mmol; Amersham Corp.). After
a further 4-h incubation, radiolabeling was terminated by washing the cells three times
with cold saline 0.02% sodium azide, and 1 mg/ml L-methionine. Washed cells were
resuspended in 2 ml of NP-40 lysis buffer (10 mM Tris-HCl, pH 7.4, 150 mM NaCl,
0.5% NP-40, 0.02% azide, and 1 mM PMSF), and incubatedfor 30 min on ice. Insoluble
material was removed by centrifuging at 10,000 g for 30 min. Cell extracts were loaded
onto a Lens culinaris affinity column for glycoprotein purification according to Hayman
and Crumpton 12). In a second series of experiments, 2 x 10' washed TCC were surface
labeled with "~ I by the lactoperoxidase catalyzed method (23). Briefly, TCC were
resuspended in 0.5 ml of cold saline to which 18,000 kBq of carrier-free sodium `461
(Amersham Corp.) was added. In rapid sequence, 30 U of lactoperoxidase (sp act, 90
U/ml ; Calbiochem-Behring Corp., San Diego, CA), 15 ul of glucose oxidase (Sigma
Chemical Co.), and 75 ul of glucose (50 mg/ml, Sigma Chemical Co.) were added, and
the reaction was stopped after 30 min by repeated washing in cold saline.246
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Imrnunoprecipitation studies were performed as previously described (24). Briefly,
labeled cell extracts were precleared with 100 jul of protein A-bearing Staphylococcus
aureus Cowan I (SACI) and 50 yl of SACI coupled to rabbit anti-mouse globulin (SACI-
RAM). 2 x 106 cell equivalents were then incubated with 1 tag of protein A-Sepharose-
purified mAbs at 4°C for I h. Immunocompiexes were then incubated with 50 gel SACI-
RAM to ensure identical binding capacity of the SACI to the various mAbs. The
precipitates were then washed three times in lysis buffer without detergent. For sequential
innnunoprecipitations, the supernatant was retained for serial transfer at each step to
tubes containing identical amounts (I Ag) of the different mAbs, followed by SACI-RAM,
and repetition of the above. At each step, material was retained for gel analysis as follows :
bound proteins were solubilized by boiling for 3 min in elution buffer containing SDS
and DTT, and visualized by electrophoresis on 12 .5% polyacrylamide slab gel (25)
followed by fixing and fluorography in Amplify (Amersham Corp.) and autoradiography
on Hyperfrlm MP (Amersham Corp.) at -70° .
(:ell-mediated Cytotoxicity Assay.
￿
Standard 5 'Cr-release assays were performed as previ-
ously described (26). Briefly, 2-5 x 10' K562 line cells were incubated with 3 .7 x 106 Bq
of sodium chromate (sp act, 22 .2 GBq/mg 5 'Cr; Amersham-Buchler, Frankfurt, FRG) in
0 .4 nil culture medium for 90 min, washed three times, and cocuitured for 4 h with
effector cells. Supernatants were removed by pipette thereafter for gamma spectroscopy.
Induction ofSuppressive Activity by T Cell Clones.
￿
2 x 106 PBMC were incubated for 3
d with 105 20 Gy-irradiated TCC in medium with 10% serum, without IL-2. Harvested
cells were then cultured with 20 U/ml of IL-2 for at least 7 d before testing by titrating
into MLC . To investigate blockade of SA induction with mAbs, 3-d PBMC + TCC
cultures were performed in the presence of 25% supernatant or 1 :100 diluted ascites.
Cells were washed, cultured in IL 2 and then added to MLC . TCC cultured alone under
these conditions did not survive, and PBMC cultured alone did not cause suppression.
Results
Restimulation of Clones Specific for DY Antigens Inhibited by mAb.
￿
In three
sensitization/cloning experiments with the same donors, ^-60% of all derived
clones showed autonomous proliferative capacity on alloantigen rechallenge. Of
these, no more than 10% recognized LADs associated with the disparate DPw
specificity of the stimulator, whereas proliferative responses of the remainder
did not correlate with any DPw specificity. The majority of stimulators elicited
either clearly positive or equivocal responses, as assessed by an objective cluster
program. Even for the unequivocally positive responses, restimulation was not
associated with the presence of any particular established class I or class II
specificity (16). Surprisingly, the spontaneous [sH]TdR incorporation of the
clones incubated with medium alone was considerably higher than that for
representative PLT clones specific for DR-, DQ-, or DP-associated LADS. More-
over, PBMCof the autologousdonor from whom the clones were derived further
stimulated these clones, although all responses were very weak compared with
DR-, DQ-, or DP-specific responses. This is illustrated for four DY-reactive
clones designated 102-1, 102-3, 105-5, and 106-13 in Fig. 1 . Titrating the
stimulating cells (Fig. 1), or altering the kinetics of restimulation (datanot shown),
indicated that not only did these response patterns remain stable, but that
autologouscells commonly stimulated more strongly than allogeneic cells. Similar
results were obtained when B-LCL instead of PBMC were used as stimulators
(Table 1) .
We attempted to characterize the stimulatory DY-LADs by blocking stimula-
tion with mAbs. A number of DR and DQ mAbs, and one DP mAb, failed toTABLE I
DY Expression on B-LCL
Stimulator
Clone
￿
Autologous
￿
Allogeneic
FIGURE 1 . Autoreactivity of
DY-specific TCC. Constant
104/wellTCC were stimulated
by titrated amounts of irradi-
ated PBMC from the same do-
noras theclones (opencircles,
autologous)or from thedonor
of the stimulating cells for the
MLC from which the clones
were derived (filled circles,
specific). Results are shown as
median cpm of triplicate cul-
tures(SEM was <12%).
Allogeneic
247
* Data presented as mean cpm t SEM oftriplicates of 104 cloned cells per well stimulated with 105 PBMC or 2.5 X 104 B-LCL cells.
block stimulation of DY-specific TCC by B-LCL, although each of the mAbs was
capable of blocking stimulation of other clones via the appropriate class II type.
Thus, the left hand panel of Fig. 2 shows the relative responses of the DY-specific
clones 102-1, 103-1, and 106-8 stimulated in the presence of a range of class II-
specific mAbs. For comparison, the right hand panel of Fig. 2 shows stimulation
inhibition patterns of the same mAb for anti-DP clone 64-2, anti-DR clone 249-
13, and anti-DQ clone 233-7. Essentially similar results were obtained by using
PBMC or stimulatory TCC instead of B-LCL as stimulators (data not shown).
Blocking of stimulation by a mixture of DR, DQ, and DP mAbs was also not
seen (data not shown). However, the broadly reactive class II-specific mAbs
TU39 and SG520, but not PL5 or DA6.231, did block stimulation by DY (Fig.
2) . Additionally, TU39 reduced the level of [3H]TdR incorporation to below
that of clones incubated in medium alone. Inhibitory effects were not caused by
nonspecific activity of the mAbs because in the presence of 20 U/ml of IL-2
proliferation was not affected by TU39 (Table II). Furthermore, pretreatment
of the stimulating cells with mAb TU39 resulted in the retention of a degree of
inhibition of stimulation (Table II).
mAb TU39 Precipitates Class H-like Molecules Different from DR, DQ, or
DP. TCC were surface labeled with 1251 and 2 x 106 cell equivalents of soluble
preparation were subjected to sequential immunoprecipitations designed to
deplete molecules reacting with well-characterized mAbs specific for mono-
PBMC B-LCL
4,378 ± 327 5,911 ± 590
10,102 t 991 9,628 t 892
4,381 t 200 6,528 ± 537
5,699 t 686 6,023 t 720
PBMC: B-LCL PBMC B-LCL
102-1 6,353 t 582* 8,972 t 549 4,316 t 335 5,291 t 938
103-1 9,568 ± 720 7,623 t 836 7,399 t 877 8,443 t 562
106-8 3,281 t 156 3,697 ± 110 2,926 t 126 3,468 t 479
106-13 7,281 ± 881 9,428 ± 1,003 5,001 t 323 5,575 t 328248
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TABLE II
64-2
DR
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Broad+DY
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￿
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￿
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￿
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DY Stimulation Inhibited by mAb T039
DP
￿
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￿
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￿
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FIGURE 2.
￿
Inhibition of stimulation by mAbs. (Left) DY-specific TCC; (rs'ght) representative
DP (64-2), DR (249-13) and DQ (233-7)-specific TCC. mAbs were as follows (from top to
bottom): DR: T084, Tb37, L243, Q2/70, and SG157; DQ: T022, SPV-L3, Leu 10; DP:
B7/21 ; broad: PL5, DA6.231 ; broad + DY: T039, SG520. Results are shown as percent
relative response compared with the value in the presence of nonbinding control mAb
(W6/32.HK).
" Stimulating cells pretreated with mAb TU99.
$ MAb'I'089 present for duration ofcoculture.
1 104 TCC were stimulated with 2.5 x 104 B-I.Cl, cells (Stimulator +) or in medium alone (stimulator -). Where IL-2 was present
(I L-2 +), 20 U/ud was used. Where mAbTOM) was present (mAb TID39 +), 25% hybridonta culture supernatant was used.
morphic epitopes of DR, DQ, or DP molecules (Fig. 3 a, lanes 1-20). Five
sequential precipitations with mAb L243 (lanes 1-S) sufficed to remove all DR
molecules (as shown by precipitation with SACI-RAM alone, lanes 6 and 7) . This
was followed on the same lysate by four precipitations with T1:J22 to remove DQ
molecules (lanes 8-11, and SACI-RAM alone, lanes 12 and 13), and finally four
sequential precipitations with 137/21 to remove DP molecules (lanes 14-17,
SACI-RAM alone, lanes 18 and 19). Finally, lane 20 shows that mAb T039 still
precipitated heterodimeric molecules similar to class II products, even after DR,
DQ, and DP molecules were depleted from the lysate.
To show that the "extra" TU39+ molecules were indeed synthesized by the
Stimulator
mAh Tii99
1l,-2
Clone,
108-I 1,869 t 290 6,492 t 690 14,287 t 1,501 2,496 t 948 758 t 114 13.634 :t 1,271
105-5 1,994 t 101 6,180 t 729 16,285 t 1,499 1,981 t 266 999 t 82 15.200 :t 1,600
106-8 1,995 t 204 9,456 t 888 22,187 t 9,009 9,059 t 422 1,055 t 296 21,864 * 2,149PAWELEC ET AL .
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FIGURE 3 . (a) mAb TU39
detects molecules other than
HLA-DR, -DQ, and -DP . 2 x
108 cell equivalents of 125I-lac-
toperoxidase surface-labeled
TCC lysates were subjected to
sequential immunoprecipita-
tion with class II-specific
mAbs followed by SDS-PAGE :
L243, lanes 1-5, and SACI-
RAM alone, lanes 6 and 7 ;
TU22, lanes 8-11, and SACI-
RAM alone, lanes 12 and 13 ;
B7/21, lanes 14-17, and
SACI-RAM alone, lanes 18
and 19 ; TU39, lane 20 . Rela-
tive positions of the a and 0
chains are indicated, as com-
pared with SDS-PAGE molec-
ular mass standards . (b) TCC
themselves synthesize TU39'
"extra" class II-like molecules.
Lysates of [sBSlmethionine
metabolically labeled TCC
were subjected to sequential
immunoprecipitations and
SDS-PAGE analysis : L243,
lanes 1-6, and SACI-RAM
alone, lanes 7 and 8 ; TU22,
lanes 9-11, and SACI-RAM
alone, lanes 12 and 13; B7/21,
lanes 14-16, and SACI-RAM
alone, lanes 17 and 18 ; TU39,
lane 19 .
TCC themselves, metabolic labeling with [s5S]methionine, followed by similar
sequential immunoprecipitation procedures, was undertaken . Results ofone such
experiment are shown in Fig. 3b . Six precipitations with L243 (lanes 1-6)
removed DR molecules (as shown by precipitation with SACI-RAM alone, lanes
7 and 8) ; next, repeated precipitations with TU22 removed DQ molecules (lanes
9-11, SACI-RAM alone, lanes 12 and 13) ; after this, precipitations with B7/21
(lanes 14-16) removed all DP molecules (SACI-RAM alone, lanes 17 and 18).
Finally, lane 19 shows that TU39 still precipitated a large amount of class II-
characteristic two-chain heterodimers also from metabolically labeled TCC.
Essentially identical results were obtained also with B-LCL (data not shown) .
Suppressive but not Helper T Cell Clones Stimulate DY-speck PLTClones .
￿
Since
certain TCC as well as B-LCL expressed novel TU39+ non-DR, -DQ, -DP
molecules, they were tested for their expression of DY by using them as stimu-
lators for PLT clones . It was found that only TCC that were suppressive for LP
responses in MLC were able to stimulate DY-specific clones . Helper TCC (defined
by their ability to help B cells to secrete Ig, data notshown) that failed to suppress
LP also failed to stimulate these reagents (Fig . 4) . Moreover, similar levels of
restimulation responses were observed whether allogeneic or autologous stimu-
lating cells were used . Thus, Fig. 4 shows the responses of the four DY-specific250
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FIGURE 4 .
￿
Cloned suppressive butnot helperT cells stimulate DY-specificPLTclones. Data
are presented as mean cpmof triplicate cultures ± SEM, after subtraction of background (cpm
of clone cultured in medium alone) of 10' responders stimulated with 105PBMC or 2.5 x 10'
TCC or B-LCL for 66 h . The asterisk denotes that the stimulator cells were derived from the
same donor as the responding cells.
PLT clones 102-1, 103-1, 106-8, and 106-13 rechallenged with a range ofTCC,
as well as with autologous and allogeneic PBMC and autologous B-LCL cells .
From these results, the expression of DY on activated TCC would seem to
correspond to their functional status . Remarkably, this also applied to the DY-
specific clones themselves, which were found to be autostimulatory, and could
respond to one another (Fig . 4) . Such clones could be stimulated equally well by
(irradiated) autochthonous cells as by cells from different clones .
Functional Activity of DY Antigens .
￿
Since only those TCC with suppressive
activity were capable of stimulating DY-specific PLT clones, and since TCC
responsive to DY were, unlike the majority of CD4+ PLT clones, themselves
suppressive (16), it seemed likely that DY could be a major regulator of suppres-
sion . This possibility was further investigated in the following experiments . DY-
specific clones 102-1, 103-1, 106-8, and 106-13 (Fig . 5, top) suppressed prolif-
eration in allogeneic MLC practically as strongly as control suppressive clones
29-31 and 38-15 (Fig . 5, bottom) . Helper TCC, on the other hand (DR5- and
DPw3-specific clones 248-3 and 64-2 in Fig . 5), generally failed to suppress
under these conditions . Moreover, other types of suppressive TCC, as well as
the DY-reactive PLT clones themselves, were able to induce SA in normal
PBMC, which was blocked by TU39 but not by anti-DR, -DQ or -DP mAb (26),
indicating the involvement of DY in the generation of suppression . When PBMC
were stimulated with DY' suppressive TCC (DY-specific PLT 106-8 or controlResponding coils per added call
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FIGURE 5. Suppressive activity in MLC of
PLT clones specific for DY LADs. Cloned cells
as shown were irradiated and titrated at the
ratios shown directly into allo-MLC in which
theresponding cells were derivedfrom adonor
mismatched for MHC classI and II specificities
with the donor of the clones. Results are ex-
pressed as percent suppression of the MLC
performed in theabsenceofadded suppressive
cells.252
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FIGURE 6.
￿
Suppressive activity in MLC of PBMC stimulated with suppressive clones. Allo-
geneic PBMC were cocultured for 3 d with the TCC shown(stimulator), followed by a further
7-dculture in purified IL-2, before irradiation andtitration at the ratios shown into ailo-MLC.
Results are expressedas percent suppression of the MLC performed in the absence o£ added
suppressive cells.
suppressive clones 29-31 and 38-15) for 3 d, followed by short-term culture in
IL-2-supplemented medium, they were found to exert potent suppressive activity
on LP responses in MLC (Fig. 6). In contrast, cell lines derived from PBMC
stimulated with DR5-specific nonsuppressive helper TCC 124-7 or 248-3 failed
to suppress (Fig. 6). In addition, to establish whether they recognized DY
determinants, these lines were stimulated with PBMC and B-LCL in the absence
of IIA. Thus, PBMC were stimulated by irradiated suppressive clone 38-15 for
3 d, followed by propagation with IL-2 for 10 d, and were then restimulated
with a range of different cells. They were found to proliferate in the presence
of most stimulator cells, including PBMC from the autologous donor, GP (Fig.
7), as well as allogeneic PBMC and B-LCL (KR), and suppressive (29-31, 38-15)
but not helper (248-3) TCC. This is a pattern characteristic of "DY"-reactive
cells. Moreover, this stimulation was preferentially blocked by mAb TU39, but
not TU22, TU34, or 137/21 (Fig. 7). In contrast, PBMC cultured under the
same conditions with non-suppressive HLA-D-specific helper TCC responded
weakly to specific allogeneic but not toautologous PBMC and B-LCL. stimulators,PAWELEC ET AL.
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FIGURE 7 .
￿
Lymphocytes primed against suppressive clones recognizeDY LADs. PBMC were
cocultured with irradiated DY* clone 38-15 cells for 3 d, followed by a further 10-d culture
in IL-2 . These cells were then restimulated for 66 h by the range of stimulating cells shown,
in the presence of control mAb W6/32.HK (data presented in the left hand panel as mean
cpm t SEM, after subtraction ofthe background) or, in the rest of the Figure, in the presence
of the class II-specific mAb shown (data presented as percentage relative response compared
with the value with W6/32.HK) .
were unable to respond to autologous T cell clones, and were inhibited by anti-
DR mAb (data not shown) .
No Further Functions of DY-specific Clones Found .
￿
DY-specific PLT clones
exhibited a peculiarly weak autonomous proliferative capacity, although they
grew well when provided with exogenous IL-2 . Increasing the amount of stim-
ulating antigen available by using larger numbers of stimulating cells did not
result in enhanced proliferative responses (Fig . 1) . Consistent with their weak
proliferative capacity, and unlike DR-, DQ-, or DP-specific PLT helper cells,
DY-reactive cells secreted very modest amounts of IL-2 into the culture medium
after stimulation (Table III) . However, they were found to produce IL-2 with
the same kinetic as other class II-reactive PLT clones, i .e ., peaking at 36-48 h
(data not shown) . Despite their CD4+, Leu-8- phenotype (16), these suppressive
TCC did not function as helpers for B cells (data not shown) . Cytolytic activity
of DY-specificTCC on NK-susceptible targets or on B-LCL was not measurable
in the "Cr-release assay (16) even in the presence of PHA and/or 20 U/ml of
IL-2 (Table IV).
Discussion
After priming between HLA-DR/Dw and DQ-matched homozygous typing
cells, a large proportion of derived clones was found to manifest weak autono-
mous proliferative activity against LADs widely distributed in the population
(16) . This peculiarly broad reactivity was not due to lack of monoclonality of the
test reagents, because Southern blotting of their DNA with TCR-S and -y chain
probes indicated monoclonal rearrangements of these genes (27) . Such clones
appeared to be similar to most DR-, DQ-, or DP-specific PLT clones in that they25 4
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TABLE III
Secretion of IL-2 by PLT Clones
* Clones were specifically stimulated for 48 h before collection of super-
natant for IL-2 assay.
Quantification of IL-2 by Probit analysis compared with the IUIS-BRMP
IL-2 standard, concentration expressed in units per milliliter.
TABLE IV
Lack of Cytotoxicity ofDY-specific TCC
4 x 10` 5 'Cr-labeled K562 cells were incubated for 4 h in the presence of TCC or PBMC at the E/T
ratios shown. Medium was supplemented with 1% PHA and/or 20 U/ml of IL-2 . Results are
expressed as percent specific "Cr release (mean of triplicates, SEM <18%).
were CD4+ and secreted IL-2, but they differed in that they exerted strong
suppressive activity on LP responses (14, 16). Although it is thought unlikely
that the suppressive activity could be due to cytotoxic effects, because these TCC
showed no killing ofsensitive target cells even in the presence of PHA and IL-2
("liable IV), it cannot be completely excluded that selective cytotoxicity on a
minor population such as dendritic cells might contribute to inhibition of LP
responses. However, the ability ofthese clones to induce suppressive activity in
normal PBMC could not be explained in the sameway. Others have alsodescribed
CD4+ Tcells with suppressor/inducer capability, in freshly isolated populations.
(:I)4+,2H4+ (CD45R+) T cells were previously identified as suppressors/inducers
(28); however, CD45R is rapidly lost from TCC during culture, regardless of
their function (29). Thus, the relationship between such CD45R+cells, and those
described here, is not clear. DY-reactive SA-inducers are also negative for
Effector E/T
Medium
Target K562
1 % PHA
in the presence of:
20 U/ml IL-2 PHA + IL-2
103-1 50:1 0.5 -1 .6 1 .5 0.2
17:1 -2.7 2 .1 0.3 -1.9
105-5 100:1 3 .1 -2.7 -2.3 0.6
33:1 1 .1 3 .4 1 .8 3.9
106-8 50:1 -6.7 -4 .2 0.8 1.5
17:1 -2.2 -1 .3 1 .7 2.2
PBMC 100:1 66.5 95 .6 67.3 88.9
33:1 48.0 65 .1 43.7 52.4
Clone* Specificity Secreted IL-2$
U/ml
102-1 DY 2.1
102-3 DY 1 .8
103-1 DY 4.3
105-5 DY 3.6
106-8 DY 5.0
64-2 DPw3 14.3
248-3 DR5 21 .6
250-7 DR5 15.2
257-6 DR5 14.9
233-7 DQw3 16.4PAWELEC ET AL.
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another marker, Leu-8 (16), which is said to identify CD4+ suppressor/inducer
cells (30) .
DY-specific TCC displayed an unusual type of autoreactivity, being restim-
ulated not only by autologous PBMC or B-LCL, but also by HLA-mismatched
allogeneic cells. Using comparable priming conditions, similar reactivities in
uncloned PLT cells have been noted previously (31), and, more recently, Martin
et al. (32) have described possibly similar findings at the clonal level (32). The
LADs involved in stimulating autoreactive lymphocyte populations have been
repeatedly shown to be, or to be associated with, class 11 molecules. Although
FACS analysis showed that helper TCC expressed quantitatively similar amounts
of DR, DQ, and DP antigens compared with the suppressive TCC (33), they
differed in theirability to stimulate "DY"-specific clones (Fig. 4). This association
of stimulatory activity with function of the clones surprisingly applied also to the
autoreactive clones themselves, since these were mutually cross-stimulatory as
well as autostimulatory. This implies that such cells areable to present DY LADs
to each other. It is somewhat puzzling, therefore, that stimulation by autologous
irradiated PBMC or autochthonous clones led to greater proliferation than
observed in medium alone, since DY-reactive cells by themselves should consti-
tute an autostimulatory circuit. Indeed, [sH]TdR incorporation by the clones in
medium alone was higher than seen for DR-, DQ- or DP-specific clones, but was
still higher in the presence of irradiated cells, even when these came from the
same clone. In the case of autostimulatory PBMC or B-LCL, a more efficient
antigen presentation, for example, by dendritic cells in the PBMC or by the
LCL, than by the TCC themselves might help to explain this apparent anomaly.
For self-stimulation by autochthonous clones, it is conceivable that the irradiated
stimulator TCC themselves would also respond to unirradiated cellsin theculture
wells by secreting IL-2. This would amplify the response of the unirradiated
cells, since one of the characteristics of the DY response is the very limited
amounts of autocrine IL-2 production by stimulated cells (Table 111).
The broad class II-reactive mAb TC39, unlike exclusively or preferentially
DR-, DQ-, or DP-specific mAbs, blocked both LP stimulatory capacity and SA-
inducing activity mediated by CD4+ suppressive, but not by CD4+ helper, TCC
(26) . The same pattern of blocking applied to stimulation of the autoreactive
clones described here (Fig. 2). Various mAbs against HLA-DR, -DQ, and -DP
failed to block stimulation of DY-specific autoreactive clones, whereas they could
block stimulation of PLT clones by appropriate alloantigens. This is consistent
with, but does not prove, the presence of DY determinants on molecules other
than DR, DQ, or DP. That stimulation of autoreactive clones was blocked by
two of four broadly reactive mAbs, SG520 and TU39 (Fig. 2), however, implies
that these clones do recognize structures bound by certain class II-specific mAbs.
Since mixtures of anti-DR, -DQ, and -DP mAbs also failed to block stimulation
(34, and data not shown), it is improbable that theclones were capable of reacting
to shared determinants on all these molecules, and therefore were not blocked
by mAbs against any single one. Blockade of DY-specific TCC stimulation by
TU39 was abrogated by exogenous IL-2 (Table 11), suggesting that the mAb
was not mediating a nonspecific inhibitory effect. Despite this, [sH]TdR incor-
poration was reduced by TU39 to below the level measured in medium alone.256
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The most likely explanation for this finding is that an autostimulatory circuit
within the clone was broken by the bindingofthe mAbto DY antigens, resulting
in blockade ofDY-directed self-stimulation. The existence of an autostimulatory
circuit within the clones would also help to explain why stimulation of DY-
specific cells after pretreating only the stimulators with mAb TU39 was not
reduced to background (Table II).
There is evidence that TU39 binds determinants other than those carried by
DR, DQ, or DP molecules. First, studies of class II expression on leukemias and
peripheral blood cells early after bone marrow transplantation demonstrated
that certain DR-,. DQ-, and DP' cells still reacted with mAb TU39, or that the
proportion ofT39-reactive cells was much higher than the sum ofDR', DQ',
and DP's cells (13, 14). Second, preliminary biochemical analyses provided
evidence consistent with TU39 reactivity on non-DR, -DQ, or -DP class II-like
molecules of very similar molecular mass to DR molecules (Fig. 3). Thus,
sequential immunoprecipitations to remove DR (and DRw, reference 35), DQ,
and DP molecules from lysates of surface-labeled TCC failed to deplete all of
the class II-like molecules with which mAb TU39 could react. Furthermore,
metabolic labeling showed that the putative novel class II-like TU3' non-DR,
-DQ, -DP molecules actually were synthesized by the TCC themselves (Fig. 3b).
In both surface-labeled and internally labeled cells, a relatively large amount of
T039-reactive material remained after depletion of the DR, DQ, and DP
molecules, emphasizing the potential novel nature of these moieties. Their
similarity to DR molecules may help to explain why they were not previously
detected in two-dimensional gel analysisofwhole lysates(24). Thepresent results
are consistent with the proposal that DY determinants, defined in functional
assays, are carried by, or associated with, the,putative novel TU39+ non-DR,
-DQ, -DP molecules demonstrated here. TheTU39+ novel class II-like molecules
were, like the functionally defined DY determinants, also expressed on B-LCL
(Table 1). Metabolic labeling has confirmed that they were also synthesized by
B-LCL (Fernandez, N., unpublished results). It will be necessary to confirm the
novelty of DY by means ofpeptide mapping and amino acid sequencing, and to
clarify the relationship between DY and established class II genes and products
at the structural level.
DO# remains a possible candidate class II gene for which a protein product
has not yet been identified. Since it is differently regulated than other class II
genes, it hasbeen suggested thatits function could also be different(9). It appears
to be a gene of a relatively low degree of polymorphism, which is consistent with
the findings pertaining to the DY LADs described here. However, DO(3 mRNA
has thus far not been found in T cells (9). DZa (8) may also be a potential
candidate for one of the DY chains, and this is known to be expressed in T cells
(8). Another candidate may be the so-called "fourth Ia subset" described by
Carra and Accolla (7), the nature of which is unknown, but which has also not
yet been demonstrated in Tcells. The retention of some LP stimulatory ability
and antigen presentation capacity by class I and class If loss-deletion mutant B-
LCL (36) also suggests the existence of functionally relevant non-DR, -DQ, or
-DP molecules, which may therefore have some relationship with DY.
DY molecules clearly may not be the products ofnew class 11 genes, but ratherPAWELEC ET AL.
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novel structures formed between a and ft chains bf different known loci to
generate mixed isotypes. The existence ofsuch mixed isotype class II molecules
has been demonstrated in mouse L cells transfected with murine class II genes
(37). The relatively large amount of non-DR, -DQ, -DP TOW molecules on
both B and T cells, and the failure thus far to isolate functional genes for class
11 moleculesother than DR, DQ (and DX), DP, DO, and DZ, wouldbeconsistent
with this possibility. Moreover, it has recently been reported that a variety of
DR-, DQ-, DP-, and DO-containing mixed isotypes can be expressed after
transfection of genes encoding the appropriate chains into L cells (11). Interest-
ingly, these products were not detectable by DR- DQ-, or DP-specific mAbs, but
were, like DY, bound by broadly reactive class II-specific mAbs. Furthermore,
the presence of such mixed isotypes has been implied, at least for DRa/DQ#
chains, in a morephysiological system on B-LCL (12). Thus, a reasonable working
hypothesis is that DY is a mixed isotype, or a group ofmixed isotypes, expressed
on B-LCL and on activated T cells other than helper cells.
A central role for DY LADs appears to be in the suppression of proliferative
responses, since all PLT clones specific for DY were highly suppressive, and
because only suppressive, but not otherwise equally class II-positive helper TCC
expressed functionally defined DY on their surfaces. T039-inhibitable stimula-
tion of LP responses in PBMC by suppressive clones is associated with induction
ofsuppression (38), and, as shown here (Fig. 7), such stimulated PBMC can also
respond to DY with limited autonomous proliferation. Autoreactive DY-respon-
sive T cells were unable to help B cell Ig production (data not shown), and were
not cytotoxic (16, Table IV). Thus far, the only effector function attributable to
such cells is non-MHC-restricted potent suppression of LP responses stimulated
in MLC (16, Fig. 5) and by mitogens and antigens (PHA and PPD, data not
shown), and, like other DY' clones, the induction of SA in PBMC (Fig. 6). Since
autoreactive clones both express and respond to DY, this would imply that the
DY-associated suppressive circuit could be self maintaining by recruitment and
by clonal expansion. However, the system presumably is kept in a steady state by
the relatively meager quantities of IL-2 produced by the autoreactive SC, so that
suppression would not always predominate, although a background level of
suppressive activity would be present.
A degree ofantigen specificity regulating the activity of the hypothesized DY-
suppressor circuit would be mediated by the local availability of higher concen-
trations of IL-2 secreted by antigen-stimulated helper cells. This would be a
simple strategy for upregulation ofDY-stimulated suppression, which would then
feed back to decrease helper function, thereby decreasing IL-2 availability,
leading to its own downregulation. Further mechanisms for control of this type
ofsuppression would undoubtedly also have to exist, possibly involving contra-
suppression (39). Some preliminary evidence is consistent with this possibility
(40).
Summary
A set of T cell clones (TCC) isolated from HLA-DR-, Dw-, DQ-matched
allogeneic MLCs was found to proliferate autonomously when stimulated with
cells carrying a wide range of class I or 11 specificities. This apparently unre-258
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stricted proliferation was relatively weak,andonly low levels ofIL-2 were present
in the supernatants of stimulated cells. Autologous as well as allogeneic PBMC
and B lymphoblastoid cell lines (B-LCL) were capable ofstimulating such clones,
which were also restimulated by suppressive, but not by helper, TCC. Moreover,
such clones displayed the unusual property of autostimulation . mAb inhibition
experiments suggested that class II- or class II-restricted antigens were involved
in stimulation. Thus, certain "broad" mAbs (TU39, SG520) reacting with mul-
tiple locus products inhibited activation of these reagents, but none of those
reacting more specifically with DR (TU34, TU37, L243, Q2/70, SG157), DQ
(TID22, SPV-L3, LeuIO), or DP (137/21), or mixtures of these mAbs, were able
to do so. Evidence from sequential immunoprecipitation experiments suggested
that mAb TU39 bound class II-like molecules other than DR, DQ, and DP on
TCC and B-LCL, and it is therefore proposed that such putative novel class A-
like molecules may carry the stimulating determinants for these autoreactive
clones. DY-reactive clones lacked helper activity for B cells but mediated potent
suppressive activity on T cell proliferative responses that was not restricted by
the HLA type ofthe responding cells. Suppressive activity was induced in normal
PBMC by such clones, as well as by independent suppressive clones, which was
also inhibited only by mAb TU39. These findings lead to the proposal that DY-
reactive autostimulatory cells may constitute a self-maintaining suppressive cir-
cuit, the level ofactivity ofwhich would be regulated primarily by the availability
of IL-2 in the microenvironment.
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